scholarly journals Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients

2009 ◽  
Vol 60 (8) ◽  
pp. 2531-2540 ◽  
Author(s):  
Benjamin Terrier ◽  
David Saadoun ◽  
Damien Sène ◽  
Jérémie Sellam ◽  
Laurent Pérard ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Severe Hepatitis ◽  
Pegylated Interferon Alfa

Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin

2007 ◽  
Vol 84 (2) ◽  
pp. 180-186 ◽  
Author(s):  
Carmen M. Stanca ◽  
M Isabel Fiel ◽  
Nickolas Kontorinis ◽  
Kaushik Agarwal ◽  
Sukru Emre ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Recurrent Hepatitis ◽  
Pegylated Interferon Alfa ◽  
Recurrent Hepatitis C

scholarly journals Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

2010 ◽  
Vol 2010 ◽  
pp. 1-3 ◽  
Author(s):  
R. Rodríguez-Lojo ◽  
M. Almagro ◽  
J. M. Barja ◽  
F. Piñeyro ◽  
L. Pérez-Varela ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Side Effects ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Hepatitis C Virus Infection ◽  
Cutaneous Side Effects ◽  
Pegylated Interferon Alfa ◽  
Nodular Vasculitis

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.

Sign in / Sign up

Export Citation Format

Share Document